| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ARBUTUS BIOPHARMA CORP | 234,000 | 573,000 | 0.50% | ||
| 52 | BLUEBIRD BIO INC COM | 9,000 | 555,000 | 0.49% | ||
| 53 | SCYNEXIS INC | 173,645 | 554,000 | 0.49% | ||
| 54 | EIGER BIOPHARMACEUTICALS INC | 40,192 | 468,000 | 0.41% | ||
| 55 | BIOCRYST PHARMACEUTICALS | 65,900 | 417,000 | 0.37% | ||
| 56 | ABEONA THERAPEUTICS INC | 76,800 | 372,000 | 0.33% | ||
| 57 | Pieris Pharmaceuticals | 223,325 | 314,000 | 0.28% | ||
| 58 | ESSA Pharma | 98,046 | 289,000 | 0.25% | ||
| 59 | NEOS THERAPEUTICS INC COM | 38,873 | 227,000 | 0.20% | ||
| 60 | CELYAD SA | 12,528 | 222,000 | 0.20% | ||
| 61 | Spring Bank Pharmaceuticals In | 27,412 | 219,000 | 0.19% | ||
| 62 | SYNERGY PHARMACEUTICALS DEL | 34,000 | 207,000 | 0.18% | ||
| 63 | AVINGER INC | 25,000 | 93,000 | 0.08% | ||
| 64 | GENVEC INC | 9,580 | 31,000 | 0.03% | ||
| 65 | BioPharmX Corporation | 77,031 | 29,000 | 0.03% | ||
| 66 | CHECK CAP LTD | 15,250 | 10,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000014, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
